Reaction
Alpha 1 Foetoprotein Increased reporting signals
As of the last recalculation, Alpha 1 Foetoprotein Increased appears in 705 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is SORAFENIB (PRR 257.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sorafenib | 144 | 257.0 | 258.8 |
| Regorafenib | 51 | 139.7 | 140.3 |
| Entecavir | 21 | 54.7 | 54.8 |
| Atezolizumab | 59 | 48.9 | 48.9 |
| Cabozantinib | 40 | 26.0 | 26.0 |
| Durvalumab | 16 | 23.7 | 23.8 |
| Ritonavir | 18 | 18.6 | 18.6 |
| Lopinavir And Ritonavir | 8 | 17.6 | 17.6 |
| Lenvatinib | 19 | 17.5 | 17.6 |
| Bleomycin Sulfate | 6 | 17.3 | 17.3 |
| Bevacizumab | 60 | 15.5 | 15.5 |
| Tenofovir Disoproxil Fumarate | 17 | 15.5 | 15.5 |
| Nevirapine | 4 | 13.2 | 13.2 |
| Peginterferon Alfa-2A | 23 | 13.0 | 13.0 |
| Rifaximin | 9 | 12.8 | 12.8 |
| Ledipasvir And Sofosbuvir | 8 | 12.4 | 12.4 |
| Ribavirin | 24 | 11.4 | 11.4 |
| Sofosbuvir | 7 | 10.6 | 10.6 |
| Glecaprevir And Pibrentasvir | 3 | 8.1 | 8.1 |